Agenda

Please see below for the IOTOD 2021 agenda*:
*Please note this is a working agenda and timings and titles are subject to change

Timings are Central European Summer Time (CEST).

Day 1 - Monday 26th April
SESSION 1 — TREATING OPIOID DEPENDENCE: WHO IS OUR PATIENT NOW?
10:45–11:10 How is the range of patient groups evolving and what is the impact for treatment providers?
11:10–11:35 Polysubstance use and the digital dealer Dr Stephan Walcher
11:35–11:45 Panel discussion
SESSION 2 — REACHING ALL OPIOID-DEPENDENT PATIENTS IN THE COVID ERA
12:00 - 12:20 COVID-19: the impact for service provision, the treatment protocols and the future Mr Duncan Hill
12:20 - 12:40 Has COVID-19 reduced / impacted stigma-related barriers to treatment to opioid dependence? Professor Catriona Matheson
12:40 - 13:00 COVID-19 and addiction: are there increased risks for opioid dependence? Dr Michael Kelleher
13:00 - 13:15 Panel discussion
13:15 - 14:15 Accord Healthcare - sponsored satellite symposium
14:15 - 15:15 AbbVie - sponsored satellite symposium
SESSION 3 — OPIOID ANALGESIA DEPENDENCE: WHERE DO WE GO FROM HERE?
15:20 - 15:45 Identification and management of OAD in patients with chronic pain Professor Maurice Dematteis
15:45 - 16:15 Multidisciplinary perspectives for prevention and management of OAD Ms Cathryn Kemp, Professor Maurice Dematteis, Ms Lucy Skea, Dr Steve Brinksman
16:15 - 16:25 Panel discussion
16:30 - 17:30 Indivior - sponsored satellite symposium
Day 2 - Tuesday 27th April
SESSION 4 — LONG-ACTING BUPRENORPHINE – THE GOOD, THE BAD, THE FUTURE?
11:00 - 11:20 Long-acting buprenorphine formulations – the story so far Professor Nicholas Lintzeris
11:20 - 11:40 Perspective beyond the prescription Professor John Marsden
11:40 - 11:55 Perspectives from across the clinic Ms Jennifer Kelly, Ms Caroline Notman
11:55 - 12:10 Panel Discussion
13:00 - 14:00 Camurus-sponsored workshop
SESSION 5 — OPTIMISING CARE: VIRAL HEPATITIS AND OST DRUG-DRUG INTERACTIONS
14:15 - 14:40 Can we do more for HBV care among PWIDs? Professor Ashley Brown
14:40 - 15:05 Why don’t more HCPs prescribe HCV drugs? Professor Graham Foster
15:05 - 15:30 OST and drug-drug interactions: looking at antivirals and beyond Mr Duncan Hill
15:30 - 15:45 Panel discussion
SESSION 6 — COMPLEX CASES: PANEL DISCUSSION
16:00 - 17:00 Complex cases: panel discussion Professor Graham Foster, Dr Stephan Walcher
Social Media Auto Publish Powered By : XYZScripts.com